Form 4 for CME CME Group
Accepted 2026-03-12 00:00:00 ET · period of report 2026-03-12 · accession 0001628280-26-017392 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-12 | 2026-03-12 | CME | Vroman Ken | Chief Transformation Off | S - Sale | $309.00 | -5,160 | 14.9K | -26% | -$1.59M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock Class A | 2026-03-12 | S | D | 5,160 | $309.00 | 14,910 | D | — | — | (F1) On March 12, 2026, Mr. Vroman sold an aggregate of 5160 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $308.969 to $309.11. The Company maintains a record of the transaction and copies will be provided upon request. |